Skip to main content
. 2012 May 1;5:109–119. doi: 10.2147/DMSO.S23261

Figure 3.

Figure 3

Proposed algorithm for pre-Ramadan review and adjustments of lifestyle and therapeutic regimens.

Adapted and modified from AlMaatouq.24 *Stable glycemic control with no major comorbidities on metformin, glitazones, alpha glucosidase inhibitors and incretin modulators.

**Fluctuating glycemia, major comorbidities esp. renal/hepatic insufficiency and/or use of insulin and sulfonylureas.